Morgan Stanley Issues Pessimistic Forecast for Accolade …

Morgan Stanley Issues Pessimistic Forecast For Accolade …

4 weeks from now

Dec 19, 2024  · Accolade (NASDAQ:ACCD – Get Free Report) had its price objective decreased by research analysts at Morgan Stanley from $6.00 to $5.00 in a note issued to investors on …

defenseworld.net

Accolade (NASDAQ:ACCD) Price Target Cut To $5.00 By Analysts At …

4 weeks from now

Dec 17, 2024  · Accolade had a negative net margin of 18.16% and a negative return on equity of 18.43%. The company's revenue for the quarter was up 9.8% on a year-over-year basis. …

marketbeat.com

Accolade Price Target Lowered To $5 From $6 At Morgan Stanley

4 weeks from now

Dec 17, 2024  · Morgan Stanley lowered the firm’s price target on Accolade to $5 from $6 and keeps an Equal Weight rating on the shares.Diversified Managed Care “woefully …

businessinsider.com

Morgan Stanley Lowers Accolade (NASDAQ:ACCD) Price Target To …

4 weeks from now

Dec 19, 2024  · Accolade (NASDAQ:ACCD – Get Free Report) had its target price dropped by equities researchers at Morgan Stanley from $6.00 to $5.00 in a research note issued on …

etfdailynews.com

Morgan Stanley Halves Price Target On Accolade To $6 From $12, …

4 weeks from now

Jun 28, 2024  · Analysts' Forecasts Income Statement Balance Sheet Cash flow Financial Ratios Business Segments ... Accolade, Inc. Presents at Morgan Stanley 22nd Annual Global …

marketscreener.com

Breaking Down Accolade: 8 Analysts Share Their Views

4 weeks from now

Dec 17, 2024  · Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $6.81, along with a high estimate of $8.00 and a low estimate …

nasdaq.com

Morgan Stanley Keeps Their Hold Rating On Accolade (ACCD)

4 weeks from now

Jun 30, 2023  · In a report released today, Craig Hettenbach from Morgan Stanley maintained a Hold rating on Accolade (ACCD – Research Report), with a price target of $14.00.The …

businessinsider.com

Accolade’s Hold Rating Affirmed Amid Conservative Outlook And …

4 weeks from now

Apr 26, 2024  · Analyst Craig Hettenbach of Morgan Stanley maintained a Hold rating on Accolade (ACCD – Research Report), with a price target of $12.00. C...

businessinsider.com

Accolade: Consider Both Short-Term Revenue Outlook And …

4 weeks from now

Sep 9, 2024  · The sell-side analysts' current consensus FY 2025 revenue growth forecast for Accolade is +12.7% as per S&P Capital IQ, which is slightly below the company's guidance. ...

seekingalpha.com

Morgan Stanley Maintains Equal-Weight On Accolade, Lowers …

4 weeks from now

Dec 17, 2024  · Morgan Stanley analyst Ricky Goldwasser maintains Accolade (NASDAQ:ACCD) with a Equal-Weight and lowers the price target from $6 to $5.

sahmcapital.com

Accolade (NASDAQ:ACCD) Stock, Analyst Ratings, Price Targets, …

4 weeks from now

Dec 31, 2018  · Accolade Inc has a consensus price target of $11.86 based on the ratings of 23 analysts. The high is $33 issued by Credit Suisse on March 3, 2022.The low is $5 issued by …

benzinga.com

Morgan Stanley Lifts Accolade’s Target Price To $60, Reiterates ...

4 weeks from now

Apr 5, 2021  · Morgan Stanley raised their stock price forecast on Accolade to $60 from $57, reiterating an “Overweight” rating on the health technology company and said the upped …

yahoo.com

Morgan Stanley Issues Pessimistic Forecast For MKS ... - MarketBeat

4 weeks from now

Dec 16, 2024  · Morgan Stanley decreased their price objective on MKS Instruments from $155.00 to $150.00 and set an "overweight" rating for the company in a report on Monday. ... Morgan …

marketbeat.com

Morgan Stanley Issues Pessimistic Forecast For Martin Marietta ...

4 weeks from now

Dec 17, 2024  · Morgan Stanley dropped their price target on shares of Martin Marietta Materials from $657.00 to $622.00 and set an "overweight" rating on the stock in a research report on …

marketbeat.com